• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外信号调节激酶1/2(ERK1/2)丝裂原活化蛋白激酶二聚化对于细胞运动的调节至关重要。

ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility.

作者信息

de la Fuente-Vivas Dalia, Cappitelli Vincenzo, García-Gómez Rocío, Valero-Díaz Sara, Amato Camilla, Rodriguéz Javier, Duro-Sánchez Santiago, von Kriegsheim Alexander, Grusch Michael, Lozano José, Arribas Joaquín, Casar Berta, Crespo Piero

机构信息

Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC) - Universidad de Cantabria, Santander, Spain.

Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

出版信息

Mol Oncol. 2025 Feb;19(2):452-473. doi: 10.1002/1878-0261.13732. Epub 2024 Sep 12.

DOI:10.1002/1878-0261.13732
PMID:39263917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11792999/
Abstract

ERK1/2 mitogen-activated protein kinases (ERK) are key regulators of basic cellular processes, including proliferation, survival, and migration. Upon phosphorylation, ERK becomes activated and a portion of it dimerizes. The importance of ERK activation in specific cellular events is generally well documented, but the role played by dimerization is largely unknown. Here, we demonstrate that impeding ERK dimerization precludes cellular movement by interfering with the molecular machinery that executes the rearrangements of the actin cytoskeleton. We also show that a constitutively dimeric ERK mutant can drive cell motility per se, demonstrating that ERK dimerization is both necessary and sufficient for inducing cellular migration. Importantly, we unveil that the scaffold protein kinase suppressor of Ras 1 (KSR1) is a critical element for endowing external agonists, acting through tyrosine kinase receptors, with the capacity to induce ERK dimerization and, subsequently, to unleash cellular motion. In agreement, clinical data disclose that high KSR1 expression levels correlate with greater metastatic potential and adverse evolution of mammary tumors. Overall, our results portray both ERK dimerization and KSR1 as essential factors for the regulation of cell motility and mammary tumor dissemination.

摘要

细胞外信号调节激酶1/2(ERK)丝裂原活化蛋白激酶是基本细胞过程的关键调节因子,包括增殖、存活和迁移。磷酸化后,ERK被激活,其中一部分会形成二聚体。ERK激活在特定细胞事件中的重要性通常有充分的文献记载,但二聚化所起的作用在很大程度上尚不清楚。在这里,我们证明,通过干扰执行肌动蛋白细胞骨架重排的分子机制,阻止ERK二聚化会妨碍细胞运动。我们还表明,一种组成型二聚化的ERK突变体本身就可以驱动细胞运动,这表明ERK二聚化对于诱导细胞迁移既是必要的也是充分的。重要的是,我们发现支架蛋白Ras 1激酶抑制因子(KSR1)是一个关键元件,它赋予通过酪氨酸激酶受体起作用的外部激动剂诱导ERK二聚化的能力,进而引发细胞运动。与此一致,临床数据显示,高KSR1表达水平与乳腺肿瘤更大的转移潜能和不良进展相关。总体而言,我们的结果表明,ERK二聚化和KSR1都是调节细胞运动和乳腺肿瘤扩散的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/200a8d6c3a30/MOL2-19-452-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/2732386748b0/MOL2-19-452-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/6e94e08bae83/MOL2-19-452-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/b6ebfe64aa91/MOL2-19-452-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/ca3500b898a4/MOL2-19-452-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/735c80db419a/MOL2-19-452-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/1a55d0c88bda/MOL2-19-452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/49127f95ba49/MOL2-19-452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/200a8d6c3a30/MOL2-19-452-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/2732386748b0/MOL2-19-452-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/6e94e08bae83/MOL2-19-452-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/b6ebfe64aa91/MOL2-19-452-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/ca3500b898a4/MOL2-19-452-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/735c80db419a/MOL2-19-452-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/1a55d0c88bda/MOL2-19-452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/49127f95ba49/MOL2-19-452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a73e/11792999/200a8d6c3a30/MOL2-19-452-g005.jpg

相似文献

1
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility.细胞外信号调节激酶1/2(ERK1/2)丝裂原活化蛋白激酶二聚化对于细胞运动的调节至关重要。
Mol Oncol. 2025 Feb;19(2):452-473. doi: 10.1002/1878-0261.13732. Epub 2024 Sep 12.
2
CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.CCL2/CCR2 趋化因子信号通过 Smad3 蛋白和 p42/44 丝裂原活化蛋白激酶(MAPK)依赖的机制协调乳腺癌细胞的存活和迁移。
J Biol Chem. 2012 Oct 19;287(43):36593-608. doi: 10.1074/jbc.M112.365999. Epub 2012 Aug 27.
3
Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement.胎盘生长因子 (PlGF) 通过促进 ERK1/2 磷酸化和细胞骨架重排来增强乳腺癌细胞的迁移能力。
Br J Cancer. 2010 Jun 29;103(1):82-9. doi: 10.1038/sj.bjc.6605746. Epub 2010 Jun 15.
4
praja2 regulates KSR1 stability and mitogenic signaling.Praja2调节KSR1的稳定性和促有丝分裂信号传导。
Cell Death Dis. 2016 May 19;7(5):e2230. doi: 10.1038/cddis.2016.109.
5
Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.Ras激酶抑制因子对于肠道上皮细胞中肿瘤坏死因子α激活细胞外信号调节激酶/丝裂原活化蛋白激酶是必需的。
Cancer Res. 2001 Feb 1;61(3):963-9.
6
Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.磷酸化作用调节KSR1稳定性、ERK激活及细胞增殖。
J Biol Chem. 2004 Nov 12;279(46):47808-14. doi: 10.1074/jbc.M406395200. Epub 2004 Sep 13.
7
The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.转录因子HOXB7调节ERK激酶活性,从而刺激胰腺癌细胞的运动性和侵袭性。
J Biol Chem. 2017 Oct 27;292(43):17681-17702. doi: 10.1074/jbc.M116.772780. Epub 2017 Sep 14.
8
Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.鉴定NEK3激酶苏氨酸165为一种新型调节性磷酸化位点,该位点调节乳腺癌细胞迁移所需的粘着斑重塑。
J Biol Chem. 2016 Oct 7;291(41):21388-21406. doi: 10.1074/jbc.M116.726190. Epub 2016 Aug 3.
9
Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.Ras 激酶抑制因子 1(KSR1)调节 PGC1α 和雌激素相关受体 α,促进致癌性 Ras 依赖性非锚定依赖性生长。
Mol Cell Biol. 2011 Jun;31(12):2453-61. doi: 10.1128/MCB.05255-11. Epub 2011 Apr 25.
10
ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.ERK2 而非 ERK1 介导了非小细胞肺癌细胞系中 HGF 诱导的迁移。
J Cell Sci. 2013 Jun 1;126(Pt 11):2381-91. doi: 10.1242/jcs.115832. Epub 2013 Apr 2.

引用本文的文献

1
All intrinsically active Erk1/2 mutants autophosphorylate threonine207/188, a plausible regulator of the TEY motif phosphorylation.所有具有内在活性的Erk1/2突变体都会自身磷酸化苏氨酸207/188,这是TEY基序磷酸化的一种可能调节因子。
J Biol Chem. 2025 Apr 11;301(6):108509. doi: 10.1016/j.jbc.2025.108509.

本文引用的文献

1
Navigating the ERK1/2 MAPK Cascade.ERK1/2 MAPK 级联途径的探索。
Biomolecules. 2023 Oct 20;13(10):1555. doi: 10.3390/biom13101555.
2
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer.乳腺癌靶向治疗和免疫治疗的临床进展。
Mol Cancer. 2023 Jul 6;22(1):105. doi: 10.1186/s12943-023-01805-y.
3
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species.支架偶联:ERK 通过不同支架蛋白物种间的转磷酸化而激活。
Sci Adv. 2023 Feb 15;9(7):eadd7969. doi: 10.1126/sciadv.add7969.
4
ERK signaling for cell migration and invasion.细胞迁移和侵袭的细胞外信号调节激酶信号传导
Front Mol Biosci. 2022 Oct 3;9:998475. doi: 10.3389/fmolb.2022.998475. eCollection 2022.
5
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER breast cancer.高 p16 表达和 RB1 杂合性缺失是 ER 型乳腺癌中 CDK4/6 抑制剂耐药的生物标志物。
Nat Commun. 2022 Sep 7;13(1):5258. doi: 10.1038/s41467-022-32828-6.
6
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer.抑制 ERK 二聚化可改善 BRAF 驱动的间变性甲状腺癌。
Cell Mol Life Sci. 2022 Sep 3;79(9):504. doi: 10.1007/s00018-022-04530-9.
7
KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.KSR1 和 ERK 依赖性调控上皮-间质转化的翻译。
Elife. 2021 May 10;10:e66608. doi: 10.7554/eLife.66608.
8
Asparagine Hydroxylation is a Reversible Post-translational Modification.天冬酰胺羟化是一种可逆的翻译后修饰。
Mol Cell Proteomics. 2020 Nov;19(11):1777-1789. doi: 10.1074/mcp.RA120.002189. Epub 2020 Aug 5.
9
ERK signalling: a master regulator of cell behaviour, life and fate.ERK 信号转导:细胞行为、生存和命运的总调控者。
Nat Rev Mol Cell Biol. 2020 Oct;21(10):607-632. doi: 10.1038/s41580-020-0255-7. Epub 2020 Jun 23.
10
p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration.p90 核糖体 S6 激酶(RSK)磷酸化肌球蛋白磷酸酶,从而控制细胞迁移过程中的边缘动力学。
J Biol Chem. 2019 Jul 12;294(28):10846-10862. doi: 10.1074/jbc.RA119.007431. Epub 2019 May 28.